
Tonje Sofie Dalen
- Research technologist; MSc, biomedicine
- +47 22 78 13 53; 415 19 541
Publications 2024
UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma - A phase II randomised trial
Eur J Cancer, 202, 113973
DOI 10.1016/j.ejca.2024.113973, PubMed 38447379